tibolone has been researched along with Local Neoplasm Recurrence in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (69.23) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E; Wilkinson, J | 1 |
Beckmann, MW; Bundred, NJ; Egberts, J; Foidart, JM; Kenemans, P; Kubista, E; Mol-Arts, M; Mulder, R; Sismondi, P; van Os, S; Vassilopoulou-Sellin, R; von Schoultz, B; Yip, CH | 1 |
Goodwin, PJ | 1 |
Antsaklis, A; Dimitrakakis, C; Keramopoulos, D; Tsigginou, A | 1 |
Beckmann, MW; Bundred, NJ; Foidart, JM; Galta, RE; Kenemans, P; Kubista, E; Lieshout, EV; Mol-Arts, M; Planellas, J; Schoultz, Bv; Sismondi, P; Vassilopoulou-Sellin, R; Yip, CH | 1 |
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E | 1 |
Agorastos, T; Bontis, J; Dinas, K; Vaitsi, V; Vakiani, A | 1 |
Metsä-Heikkilä, M; Ylikorkala, O | 1 |
Bundred, NJ; Turner, LE | 1 |
Bundred, N; Fentiman, IS; Foidart, JM; Helmond, FA; Kroiss, R; Kubista, E; Mol-Arts, M; Rymer, J | 1 |
Anderson, GL; Chlebowski, RT | 1 |
Bredakis, N; Dimitrakakis, C; Gaki, V; Keramopoulos, A; Keramopoulos, D; Vourli, G | 1 |
Beckmann, MW; Bundred, NJ; Egberts, J; Foidart, JM; Kenemans, P; Kubista, E; Planellas, J; Sismondi, P; van Os, S; Vassilopoulou-Sellin, R; von Schoultz, B; Yip, CH | 1 |
4 review(s) available for tibolone and Local Neoplasm Recurrence
Article | Year |
---|---|
Short-term and long-term effects of tibolone in postmenopausal women.
Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Stroke; Sweating; Uterine Hemorrhage | 2016 |
Short and long term effects of tibolone in postmenopausal women.
Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Stroke; Sweating; Uterine Hemorrhage | 2012 |
Hormone replacement therapy in women with a history of breast cancer.
Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Quality of Life; Risk Factors; Selective Estrogen Receptor Modulators | 2002 |
Postmenopausal hormone therapy before and after breast cancer: clinical experiences.
Topics: Breast Neoplasms; Female; Hormone Replacement Therapy; Humans; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators | 2004 |
6 trial(s) available for tibolone and Local Neoplasm Recurrence
Article | Year |
---|---|
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Osteoporosis, Postmenopausal; Vasomotor System | 2009 |
What have we really learned from 'LIBERATE' trial?
Topics: Breast Neoplasms; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes | 2010 |
Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy.
Topics: Adult; Aged; Analysis of Variance; Body Mass Index; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Osteoporosis; Selective Estrogen Receptor Modulators; Survivors | 2012 |
The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Endometrium; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Hyperhidrosis; Lipids; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Pilot Projects; Postmenopause; Tamoxifen | 2005 |
Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Prospective Studies; Tamoxifen | 2005 |
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Autonomic Nervous System Diseases; Bone Density; Breast Neoplasms; Double-Blind Method; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Norpregnenes; Quality of Life; Survival Analysis; Tamoxifen; Treatment Outcome; Vasomotor System | 2007 |
3 other study(ies) available for tibolone and Local Neoplasm Recurrence
Article | Year |
---|---|
Tibolone: the risk is too high.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Estrogen Replacement Therapy; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Risk | 2009 |
Atypical endometrial hyperplasia in an 18-year-old woman.
Topics: Adolescent; Clomiphene; Diagnosis, Differential; Endometrial Hyperplasia; Female; Humans; Leuprolide; Neoplasm Recurrence, Local; Norpregnenes; Precancerous Conditions; Progestins; Ultrasonography | 2003 |
Progestins and recurrence in breast cancer survivors.
Topics: Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Europe; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Progestins; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Survivors; Treatment Outcome | 2005 |